Pentagon Quietly Tests ‘Eight-Figure’ Device as Havana Syndrome Mystery Deepens

The US Defense Department has spent more than a year testing a device obtained through an undercover purchase that some investigators believe could be connected to the baffling cluster of illnesses widely known as Havana Syndrome — a development that has reignited one of Washington’s most divisive national security debates.

The device, bought for “eight figures” and reportedly portable enough to fit inside a backpack, was acquired by Homeland Security Investigations (HSI), a law-enforcement arm of the Department of Homeland Security. The purchase was made using Pentagon funding in the final stretch of the Biden administration, according to multiple people briefed on the matter, as CNN reported.

For officials who have spent years wrestling with what the government formally calls “anomalous health incidents” (AHIs), the testing underscores two uncomfortable realities at once: first, that dozens of reported cases still lack a definitive explanation — and second, that the question of whether some kind of directed-energy technology could be involved remains politically and emotionally explosive.

A device at the center of a long-running mystery

According to those briefed, the device under evaluation generates pulsed radio waves — one of the mechanisms that some officials and academics have speculated about for years. The central puzzle has always been practicality: could something powerful enough to cause the symptoms some victims describe be made small, portable, and discreet?

That is why the device’s reported form factor matters. If a device can fit into a backpack and still generate meaningful effects, it could shift the debate from the realm of theory into a more concrete, testable space — though it would not, on its own, prove causation in any specific incident.

Even inside government, the reported testing has not produced a unified view. There is ongoing debate — and, in some quarters, skepticism — about whether the device is linked to the unresolved cases at all. The Pentagon and relevant agencies have been asked for comment, while intelligence officials have largely avoided discussing operational details publicly.

What is Havana Syndrome — and why it still divides Washington

The term “Havana Syndrome” dates to late 2016, when US diplomats in Havana began reporting symptoms consistent with head trauma: vertigo, severe headaches, dizziness, nausea, and cognitive difficulties. In subsequent years, similar reports emerged in other parts of the world, involving not just diplomats but also intelligence officers, military personnel, and sometimes family members.

From the start, the hardest part has been the lack of a single clean diagnostic signature. Some victims describe sudden, acute episodes with lasting effects; others report symptoms that overlap with more conventional conditions. In some cases, evaluations were conducted long after the initial onset, making it harder to reconstruct what physically occurred.

This uncertainty has created fertile ground for conflict: victims and advocates argue that the government has minimized their experiences, while officials have struggled to reconcile inconsistent medical evidence, uneven reporting standards, and a geopolitically charged hunt for attribution.

What the intelligence community has said — and what it hasn’t

Publicly, the intelligence community’s broad position has been cautious. In its most recent updated assessment, the Office of the Director of National Intelligence stated that it is “very unlikely” or “unlikely” that any foreign actor caused the incidents reported as possible AHIs — while still acknowledging uncertainty at the margins and differing views across components.

The unclassified ODNI assessment also notes ongoing interest in the question of foreign capability and research progress — but stops short of attributing the incidents to a foreign campaign. Readers can review the assessment directly in ODNI’s Updated Assessment of Anomalous Health Incidents.

Those distinctions matter because “not proven” cuts two ways. It does not confirm an attack. But it also leaves room for continued inquiry — the space where the newly tested device now sits.

Why the device testing raises new fears

One concern voiced by officials briefed on the matter is proliferation. If a form of technology proves viable — even if it does not explain the majority of reported incidents — the mere existence of a portable device that can generate targeted radiofrequency pulses could raise security questions across embassies, bases, and intelligence facilities.

That anxiety is amplified by the fact that investigators have long faced basic unknowns: where these incidents originated, whether they share a common cause, and whether a subset could stem from hostile action while others do not. If the answer is messy — “some yes, many no” — policy becomes harder, not easier.

It also reframes the operational risk. Diplomats and intelligence officers have always been exposed to conventional threats. But the possibility of an invisible technology that could cause disruptive, career-altering symptoms — without leaving clear forensic fingerprints — is the kind of scenario that keeps counterintelligence officials awake at night.

What happens next

For now, the device remains under study, and the story remains defined by what it does not resolve. It does not prove Havana Syndrome was caused by directed energy. It does not identify a perpetrator. And it does not erase the medical and investigative complexity that has dogged the issue for nearly a decade.

What it does do is push the debate back into the foreground — not as a closed case, but as a live question with real consequences for health care, disability support, intelligence oversight, and diplomatic security.

In Washington, the next phase will likely unfold along two tracks at once: scientists and technical teams trying to determine what the device can do in controlled conditions, and policymakers trying to decide what level of risk to assume while answers remain incomplete. Between those tracks sit the victims — many of whom say they have lived for years with symptoms, uncertainty, and a sense that the system has not taken them seriously.

That mix of secrecy, suffering, and suspicion is why Havana Syndrome has never stayed buried for long — and why, with a new device now under scrutiny, the mystery is deepening again.